← Leaderboards
Richard Syd Kornbluth
University Of California San Diego
$3,601,719
Attributed
$3,601,719
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $517.3K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,376,719 · 10
CDC$225,000 · 1
By mechanism
R21$1,819,702 · 5
R43$1,266,199 · 4
P30$281,143 · 1
R01$234,675 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Flossie Wong-Staal$1,854,235
- William Fenical$13,401,375
- Stephen A Spector$452,436
- David James Looney$5,128,211
Others in their field
Top investigators on “Vaccination”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinationAntibodiesResearch StudyVaccinesPreventPublic Health RelevanceReceptorProteinsResponseCellsCd40 LigandCd8b1 GeneT-LymphocyteMediatingB-LymphocytesAdjuvantAntiviral AgentsPlasmidsKillingsLaboratory MouseAntigensCell LineClinical ResearchLigands
Grant awards (17)
MagaVax vaccine for Ebola$225,000
R43 · FY2016 · CK · contact PI
MagaVax Therapeutic Vaccine for Chronic HBV infection$223,899
R43 · FY2015 · DK · contact PI
Development of a multimeric CD40 ligand vaccine adjuvant$293,401
R43 · FY2014 · AI · contact PI
Ovarian cancer therapy using CD40 Ligand (CD40L)$223,899
R43 · FY2014 · CA · contact PI
Development of a multimeric CD40 ligand vaccine adjuvant$300,000
R43 · FY2013 · AI · contact PI
Precision immunization vaccine for nicotine and other drugs of abuse$169,750
R21 · FY2011 · DA · contact PI
Precision immunization vaccine for nicotine and other drugs of abuse$175,000
R21 · FY2010 · DA · contact PI
Vaccines to Generate Neutralizing Anti-HIV Antibodies$135,967
R21 · FY2008 · AI · contact PI
Vaccines to Generate Neutralizing Anti-HIV Antibodies$242,550
R21 · FY2007 · AI · contact PI
Combined TNFSF and TLR stimulation of HIV vaccines$211,510
R21 · FY2006 · AI · contact PI
Combined TNFSF and TLR stimulation of HIV vaccines$216,600
R21 · FY2005 · AI
TNFSF APC activators for HIV Vaccines$211,050
R21 · FY2003 · AI
Regulation of HIV-1 Preintegration Complexes (PICs)$246,225
R21 · FY2002 · AI
TNFSF APC activators for HIV Vaccines$211,050
R21 · FY2002 · AI
CORE--VIRAL PATHOGENESIS$180,480
P30 · FY2001 · AI
IMMUNE AND THERAPEUTIC SUPPRESSION OF HIV IN THE LUNG$234,675
R01 · FY2000 · HL
CORE--VIRAL PATHOGENESIS$100,663
P30 · FY2000 · AI